Monmouth Jct., NJ, United States of America

Yike Ni


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yike Ni: Innovator in Neurological Treatments

Introduction

Yike Ni is a notable inventor based in Monmouth Junction, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating neurological disorders. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Yike Ni holds a patent for "Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders." This invention relates to imidazo[1,5-a]quinoxaline derivatives, which are designed to inhibit phosphodiesterase 10 (PDE10). These compounds are intended for use in treating central nervous system diseases in mammals, including humans. The patent outlines the processes for preparing these compounds, as well as their pharmaceutical applications.

Career Highlights

Throughout her career, Yike Ni has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Wyeth and Elbion GmbH, where she has contributed to various research and development projects. Her work has been instrumental in advancing the understanding and treatment of neurological conditions.

Collaborations

Yike Ni has collaborated with several professionals in her field, including Michael Sotirios Malamas and James Joseph Erdei. These collaborations have enriched her research and have played a crucial role in the development of her patented inventions.

Conclusion

Yike Ni's contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders, highlight her innovative spirit and dedication to improving human health. Her patent and collaborations reflect her commitment to advancing medical science and providing solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…